Trials / Completed
CompletedNCT00440570
A Study of Therapeutic Amplitude-modulated Electromagnetic Fields in Advanced Tumors
Treatment of Advanced Cancer With Amplitude-modulated Electromagnetic Fields of Low Intensity by Means of an Intrabuccal Probe
- Status
- Completed
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 2 (planned)
- Sponsor
- Pasche, Boris, M.D. · Individual
- Sex
- All
- Age
- 18 Years – 95 Years
- Healthy volunteers
- Accepted
Summary
In vitro studies suggest that low levels of amplitude-modulated electromagnetic fields may modify cell growth. We have identified specific frequencies that may block cancer cell growth. We have developed a device delivering low levels of amplitude-modulated electromagnetic fields. The device is connected to a spoon-like coupler, which is placed in the patient's mouth during treatment. We will conduct a feasibility study consisting of three daily ambulatory treatments until disease progression.
Detailed description
Background: In vitro studies suggest that low levels of amplitude-modulated electromagnetic fields may modify cell growth. We have identified specific frequencies that may block cancer cell growth. We have developed a portable and programmable device delivering low levels of amplitude-modulated electromagnetic fields. The device is connected to a spoon-like coupler, which is placed in the patient's mouth during treatment. Methods: We will conducted a feasibility study consisting of three daily treatments. All patients with advanced solid tumors and measurable disease will be eligible, irrespective of prior treatments. Patients will be assessed with laboratory exams (complete blood count, comprehensive profile, tumor markers), imaging studies every other month for the first six months, every third month thereafter.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Low levels of amplitude-modulated electromagnetic fields | |
| DEVICE | Emitter of low levels of amplitude-modulated electromagnetic fields |
Timeline
- Start date
- 2004-10-01
- Primary completion
- 2006-09-01
- Completion
- 2007-12-01
- First posted
- 2007-02-27
- Last updated
- 2011-06-29
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT00440570. Inclusion in this directory is not an endorsement.